Suchergebnisse - "Kirchgesner, Julien"

PubPharm (116)

71

Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area

enthalten in: Clinics and research in hepatology and gastroenterology | 2020

von Becq, A. | Jais, B. | Fron, C. | +35

72

Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease : Review of the Literature and Expert Panel Statement

enthalten in: Angiology | 2020

von Zanoli, L. | Mikhailidis, D. | Bruno, R. | +14

73

Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Martin, A. | Nachury, M. | Peyrin-Biroulet, L. | +62

74

Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Salameh, R. | Kirchgesner, J. | Allez, M. | +5

CommentIn: Aliment Pharmacol Ther. 2020 Oct;52(7):1251. - PMID 33016555

75

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis : a GETAID multicentre real-world cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Amiot, A. | Filippi, J. | Abitbol, V. | +65

ErratumIn: Aliment Pharmacol Ther. 2020 Nov;52(9):1533. - PMID 33263381

76

Risk of acute arterial events associated with treatment of inflammatory bowel diseases : nationwide French cohort study

enthalten in: Gut | 2020

von Kirchgesner, J. | Nyboe Andersen, N. | Carrat, F. | +18

CommentIn: Gut. 2022 Nov;71(11):2373-2374. - PMID 35017198

77

The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Alric, H. | Amiot, A. | Kirchgesner, J. | +6

CommentIn: Aliment Pharmacol Ther. 2020 Aug;52(3):561-562. - PMID 32656826

78

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Beaugerie, L. | Rahier, J. | Kirchgesner, J.

CommentIn: Clin Gastroenterol Hepatol. 2021 Mar;19(3):621-622. - PMID 33248086

79

Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines

enthalten in: United European gastroenterology journal | 2020

von Wisniewski, A. | Kirchgesner, J. | Seksik, P. | +8

80

Impact of Aphthous Colitis at Diagnosis on Crohn's Disease Outcomes

enthalten in: Journal of Crohn's & colitis | 2020

von Delattre, C. | Lewis, A. | Kirchgesner, J. | +7